Belongs to

• Center for Hematologic Malignancies

Types of Work

["2023"]

[[["Meeting Abstracts",1531],["Journal Articles",1197],["Reviews",75],["Research Letters",48],["Book Sections",34],["Guidelines",26],["Editorials",24],["Correspondences",18],["Conference Papers",14],["Book Wholes",1],["Miscellaneous",1]]]

[2969]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• hematopoietic stem cell transplantation
• human
• humans
• major clinical study
• male

Recent Works

1. Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience

   Journal Article

   Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
   Blood Neoplasia (2025)

   Fulltext@MSK | Save
2. Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

   Journal Article

   Burton, H.; Boussi, L.; Nemirovsky, D.; Derkach, A.; Ciervo, J.; Famulare, C.; Chin, K. K.; Valtis, Y.; Yisraeli Salman, M.; Patel, K.; more...
   Cancer (2025)

   Fulltext@MSK | Save
3. Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

   Correspondence

   Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
   Blood Cancer Journal (2025)

   Fulltext@MSK | Save